These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35138021)

  • 1. Youth with type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: A Pediatric Diabetes Consortium study.
    Wolf RM; Cheng P; Gal RL; Beaulieu LC; Kollman C; Isganaitis E; Magge S; Mastrandrea LD; Klingensmith GJ; Tamborlane W; Van Name M;
    Pediatr Diabetes; 2022 Jun; 23(4):439-446. PubMed ID: 35138021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of treatment patterns among youth with type 2 diabetes.
    Badaru A; Klingensmith GJ; Dabelea D; Mayer-Davis EJ; Dolan L; Lawrence JM; Marcovina S; Beavers D; Rodriguez BL; Imperatore G; Pihoker C
    Diabetes Care; 2014; 37(1):64-72. PubMed ID: 24026554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical trial to maintain glycemic control in youth with type 2 diabetes.
    ; Zeitler P; Hirst K; Pyle L; Linder B; Copeland K; Arslanian S; Cuttler L; Nathan DM; Tollefsen S; Wilfley D; Kaufman F
    N Engl J Med; 2012 Jun; 366(24):2247-56. PubMed ID: 22540912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry.
    Bacha F; Cheng P; Gal RL; Kollman C; Tamborlane WV; Klingensmith GJ; Manseau K; Wood J; Beck RW;
    Horm Res Paediatr; 2018; 89(1):47-55. PubMed ID: 29131017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium.
    Klingensmith GJ; Connor CG; Ruedy KJ; Beck RW; Kollman C; Haro H; Wood JR; Lee JM; Willi SM; Cengiz E; Tamborlane WV;
    Pediatr Diabetes; 2016 Jun; 17(4):266-73. PubMed ID: 25951940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic control in youth-onset type 2 diabetes correlates with weight loss.
    Chang N; Yeh MY; Raymond JK; Geffner ME; Ryoo JH; Chao LC
    Pediatr Diabetes; 2020 Nov; 21(7):1116-1125. PubMed ID: 33103329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin.
    Jalaludin MY; Deeb A; Zeitler P; Garcia R; Newfield RS; Samoilova Y; Rosario CA; Shehadeh N; Saha CK; Zhang Y; Zilli M; Scherer LW; Lam RLH; Golm GT; Engel SS; Kaufman KD; Shankar RR
    Pediatr Diabetes; 2022 Mar; 23(2):183-193. PubMed ID: 34779103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth Hormone Mediators and Glycemic Control in Youths With Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.
    Lu C; Wolfs D; El Ghormli L; Levitsky LL; Levitt Katz LE; Laffel LM; Patti ME; Isganaitis E
    JAMA Netw Open; 2024 Feb; 7(2):e240447. PubMed ID: 38421647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postintervention Effects of Varying Treatment Arms on Glycemic Failure and β-Cell Function in the TODAY Trial.
    TODAY Study Group
    Diabetes Care; 2021 Jan; 44(1):75-80. PubMed ID: 33290248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.
    Rajpathak SN; Rajgopalan S; Engel SS
    J Diabetes Complications; 2014; 28(6):831-5. PubMed ID: 25104238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.
    Zhang Y; Zhao Z; Wang S; Zhu W; Jiang Y; Sun S; Chen C; Wang K; Mu L; Cao J; Zhou Y; Gu W; Hong J; Wang W; Ning G
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28609547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world treatment escalation from metformin monotherapy in youth-onset Type 2 diabetes mellitus: A retrospective cohort study.
    Vajravelu ME; Hitt TA; Amaral S; Levitt Katz LE; Lee JM; Kelly A
    Pediatr Diabetes; 2021 Sep; 22(6):861-871. PubMed ID: 33978986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia.
    Ross SA; Caballero AE; Del Prato S; Gallwitz B; Lewis-D'Agostino D; Bailes Z; Thiemann S; Patel S; Woerle HJ; von Eynatten M
    Postgrad Med; 2016 Nov; 128(8):747-754. PubMed ID: 27684308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study.
    Kelsey MM; Geffner ME; Guandalini C; Pyle L; Tamborlane WV; Zeitler PS; White NH;
    Pediatr Diabetes; 2016 May; 17(3):212-21. PubMed ID: 25690268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):854-65. PubMed ID: 9742977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to failure of oral therapy in children with type 2 diabetes: a single center retrospective chart review.
    Barnes NS; White PC; Hutchison MR
    Pediatr Diabetes; 2012 Nov; 13(7):578-82. PubMed ID: 22646303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.